Document Detail


Postsynaptic alpha 1-blockade with terazosin does not modify insulin sensitivity in nonobese normotensive subjects.
MedLine Citation:
PMID:  1719277     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Plasma insulin levels and the sensitivity of peripheral tissue to insulin (SI) have pathophysiological, therapeutic, and possibly also prognostic relevance. To investigate the effects of short-term selective alpha 1-adrenergic receptor blockade in nonobese normotensive humans on glucose and lipoprotein homeostasis, we assessed SI (determined by the minimal model method of Bergman), before and after glucose load plasma, glucose, and insulin levels, serum total triglycerides and lipoprotein cholesterol fractions, and some other variables in 20 healthy young men (26 +/- 1 years old, mean +/- SEM) during placebo and after 5 weeks of terazosin administration at a dose up to 10 mg once daily. Measurements were made after 3 days of standard diet (2,500 kcal/day, 45% carbohydrates, 40% fat, and 15% proteins) and after an overnight fast. Compared to placebo, terazosin decreased the upright systolic blood pressure (placebo vs. terazosin: 125 +/- 2 vs. 117 +/- 2 mm Hg, p less than 0.05) and increased supine (63 +/- 2 vs. 70 +/- 1 beats/min, p less than 0.05) and upright (77 +/- 2 vs. 88 +/- 2 beats/min, p less than 0.01) heart rates, while the body weight was unaltered. Terazosin did not significantly modify fasting plasma glucose (5.08 +/- 0.09 vs. 5.23 +/- 0.08 mmol/L, respectively), or insulin (8.9 +/- 0.5 vs. 8.6 +/- 0.6 microU/ml), SI (14.3 +/- 1.8 vs 11.8 +/- 1.5 x 10(-4)/min/microU/ml), the areas under the insulin or glucose curves, serum total triglycerides, and cholesterol or lipoprotein cholesterol fractions.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
P Ferrari; J Rosman; N Neuner; S Shaw; W Riesen; P Weidmann
Related Documents :
3550377 - The synthetic 32-46 fragment of human growth hormone increases insulin and glucagon lev...
22882797 - Sex-specific outcomes of diabetic patients with acute myocardial infarction who have un...
22760567 - The lack of effect of insulin on luteinizing hormone pulsatility in healthy male volunt...
22313327 - Development and psychometric validation of the diabetes therapy-related qol (dtr-qol) q...
25222757 - High insulin combined with essential amino acids stimulates skeletal muscle mitochondri...
15043177 - Glycemic control in medical inpatients with type 2 diabetes mellitus receiving sliding ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  18     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1991 Jul 
Date Detail:
Created Date:  1991-12-18     Completed Date:  1991-12-18     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  106-10     Citation Subset:  IM    
Affiliation:
Medizinische Poliklinik, University of Berne, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic alpha-Antagonists / pharmacology*
Adrenergic beta-Antagonists / pharmacology*
Adult
Blood Glucose / metabolism
Blood Pressure / drug effects
Body Weight / drug effects
Cholesterol / blood
Drug Tolerance
Heart Rate / drug effects
Humans
Insulin / blood*
Iodine Radioisotopes / diagnostic use
Lipoproteins / blood
Male
Prazosin / analogs & derivatives*,  pharmacology
Radioimmunoassay
Triglycerides / blood
Chemical
Reg. No./Substance:
0/Adrenergic alpha-Antagonists; 0/Adrenergic beta-Antagonists; 0/Blood Glucose; 0/Iodine Radioisotopes; 0/Lipoproteins; 0/Triglycerides; 11061-68-0/Insulin; 19216-56-9/Prazosin; 57-88-5/Cholesterol; 63590-64-7/Terazosin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Nebivolol increases survival in cardiomyopathic hamsters with congestive heart failure.
Next Document:  Effects of amiodarone with and without polysorbate 80 on myocardial oxygen consumption and coronary ...